Muscle-loss concerns lead to new drug discovery platform ProFuse’s novel technology addresses the growing need to preserve muscle in the face of aging and the popularity of weight-loss drugs.

https://www.israel21c.org/muscle-loss-concerns-lead-to-new-drug-discovery-platform/ Israeli startup ProFuse Technology has launched a new drug discovery platform that seeks to prevent muscle mass loss caused by aging, cancer and the growing use of glucagon-like peptide-1 (GLP-1) weight-loss injections, such as Ozempic. By Yulia Karra April 17